A second Ebola case has been confirmed in the latest outbreak in the Democratic Republic of the Congo (DRC), a city health official from the city of Beni told Reuters.
The World Health Organization (WHO) today released a new tool to help countries calculate the costs of implementing multisectoral national action plans (NAPs) for antimicrobial resistance (AMR).
In the weeks before the boy got sick, 3 of his neighbors—a father and 2 kids—died from a similar illness but weren't tested.
The World Health Organization (WHO) and its partners today called for urgent action to address meningitis, while launching the first ever global strategy to battle the disease, called the Global Roadmap to Defeat Meningitis by 2030.
By 2030, the goals are to eliminate epidemics of bacterial meningitis—the deadliest form of the disease—and to reduce deaths by 70% and halve the number of cases, the WHO said in a press release.
Admission screening for carbapenem-resistant Enterobacterales (CRE) at a Vietnamese children's hospital was associated with reduced CRE acquisition, hospital-acquired infections (HAIs), duration of hospital stay, and costs, according to a study published this week in Antimicrobial Resistance and Infection Control.
Early use of convalescent plasma didn't prevent COVID-19 progression in a group of high-risk adult outpatients, concludes a National Institutes of Health (NIH) study yesterday in the New England Journal of Medicine (NEJM).
The Ivory Coast yesterday launched an Ebola vaccination campaign aimed at frontline health workers and other high-risk groups, part of the response into an imported Ebola case involving a woman who had just arrived from Guinea.
A WHO official says the case is concerning because it was detected in Abidjan, a city of 4 million people, but it's not linked to an earlier outbreak in Guinea.
In Brooklyn, New York, communities with higher rates of poverty and minorities may have less access to COVID-19 vaccination sites, according to a JAMA Network Open research letter late last week.
The use of rapid respiratory pathogen (RRP) testing among children with influenza-like illness (ILI) did not reduce antibiotic prescribing, according to a randomized clinical trial published late last week in JAMA Network Open.
